{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:50:26Z","timestamp":1761126626554,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":30,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540857716"},{"type":"electronic","value":"9783540857723"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-540-85772-3_12","type":"book-chapter","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T09:10:18Z","timestamp":1303290618000},"page":"273-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Allogeneic Transplantation in Multiple Myeloma"],"prefix":"10.1007","author":[{"given":"G\u00f6sta","family":"Gahrton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,19]]},"reference":[{"key":"12_CR1_12","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.exphem.2007.08.006","volume":"35","author":"E Alici","year":"2007","unstructured":"Alici E, Konstantinidis KV, Sutlu T, Aints A, Gahrton G, Ljunggren HG, Dilber MS (2007) Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model. Exp Hematol 35:1839\u20131846","journal-title":"Exp Hematol"},{"key":"12_CR2_12","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1182\/blood-2007-09-110312","volume":"111","author":"E Alici","year":"2008","unstructured":"Alici E, Sutlu T, Bjorkstrand B, Gilljam M, Stellan B, Nahi H, Quezada HC, Gahrton G, Ljunggren HG, Dilber MS (2008) Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components. Blood 111:3155\u20133162","journal-title":"Blood"},{"key":"12_CR3_12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3324\/haematol.12665","volume":"93","author":"F Ayuk","year":"2008","unstructured":"Ayuk F, Perez-Simon JA, Shimoni A, Sureda A, Zabelina T, Schwerdtfeger R, Martino R, Sayer HG, Alegre A, Lahuerta JJ, Atanackovic D, Wolschke C, Nagler A, Zander AR, San Miguel JF, Kroger N (2008) Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation. Haematologica 93:1343\u20131350","journal-title":"Haematologica"},{"key":"12_CR4_12","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","volume":"88","author":"BB Bjorkstrand","year":"1996","unstructured":"Bjorkstrand BB, Ljungman P, Svensson H, Hermans J, Alegre A, Apperley J, Blade J, Carlson K, Cavo M, Ferrant A, Goldstone AH, de Laurenzi A, Majolino I, Marcus R, Prentice HG, Remes K, Samson D, Sureda A, Verdonck LF, Volin L, Gahrton G (1996) Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 88:4711\u20134718","journal-title":"Blood"},{"key":"12_CR5_12","first-page":"S38","volume":"41","author":"B Bj\u00f6rkstrand","year":"2008","unstructured":"Bj\u00f6rkstrand B, Iacobelli S, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Musto P, Beksac M, Bosi A, Milone P, Corradini P, Goldschmidt H, De Witte T, Morris C, Niederwieser D, Gahrton G (2008) Autologous stem cell transplantation (ASCT) versus ASCT followed by redued- intensity conditioning allogeneic SCT with identical sibling donor in previously untreated multiple myeloma: prelliminary analysis of a prospective controlled trial by the EBMT. Bone Marrow Transplant 41:S38","journal-title":"Bone Marrow Transplant"},{"key":"12_CR6_12","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1056\/NEJMoa065464","volume":"356","author":"B Bruno","year":"2007","unstructured":"Bruno B, Rotta M, Patriarca F, Mordini N, Allione B, Carnevale-Schianca F, Giaccone L, Sorasio R, Omede P, Baldi I, Bringhen S, Massaia M, Aglietta M, Levis A, Gallamini A, Fanin R, Palumbo A, Storb R, Ciccone G, Boccadoro M (2007) A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med 356:1110\u20131120","journal-title":"N Engl J Med"},{"key":"12_CR7_12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1200\/JCO.1999.17.1.208","volume":"17","author":"P Corradini","year":"1999","unstructured":"Corradini P, Voena C, Tarella C, Astolfi M, Ladetto M, Palumbo A, Van Lint MT, Bacigalupo A, Santoro A, Musso M, Majolino I, Boccadoro M, Pileri A (1999) Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol 17:208\u2013215","journal-title":"J Clin Oncol"},{"key":"12_CR8_12","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1182\/blood-2003-01-0189","volume":"102","author":"P Corradini","year":"2003","unstructured":"Corradini P, Cavo M, Lokhorst H, Martinelli G, Terragna C, Majolino I, Valagussa P, Boccadoro M, Samson D, Bacigalupo A, Russell N, Montefusco V, Voena C, Gahrton G (2003) Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. Blood 102:1927\u20131929","journal-title":"Blood"},{"key":"12_CR9_12","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1182\/blood-2006-07-036848","volume":"109","author":"C Crawley","year":"2007","unstructured":"Crawley C, Iacobelli S, Bjorkstrand B, Apperley JF, Niederwieser D, Gahrton G (2007) Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning. Blood 109:3588\u20133594","journal-title":"Blood"},{"key":"12_CR10_12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3324\/haematol.13555","volume":"93","author":"G Gahrton","year":"2008","unstructured":"Gahrton G, Bjorkstrand B (2008) Allogeneic transplantation in multiple myeloma. Haematologica 93:1295\u20131300","journal-title":"Haematologica"},{"key":"12_CR11_12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM199110313251802","volume":"325","author":"G Gahrton","year":"1991","unstructured":"Gahrton G, Tura S, Ljungman P, Belanger C, Brandt L, Cavo M, Facon T, Granena A, Gore M, Gratwohl A et al (1991) Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation. N Engl J Med 325:1267\u20131273","journal-title":"N Engl J Med"},{"key":"12_CR12_12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","volume":"113","author":"G Gahrton","year":"2001","unstructured":"Gahrton G, Svensson H, Cavo M, Apperly J, Bacigalupo A, Bjorkstrand B, Blade J, Cornelissen J, de Laurenzi A, Facon T, Ljungman P, Michallet M, Niederwieser D, Powles R, Reiffers J, Russell NH, Samson D, Schaefer UW, Schattenberg A, Tura S, Verdonck LF, Vernant JP, Willemze R, Volin L (2001) Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983\u201393 and 1994\u201398 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 113:209\u2013216","journal-title":"Br J Haematol"},{"key":"12_CR13_12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.bmt.1704861","volume":"35","author":"G Gahrton","year":"2005","unstructured":"Gahrton G, Iacobelli S, Apperley J, Bandini G, Bjorkstrand B, Blade J, Boiron JM, Cavo M, Cornelissen J, Corradini P, Kroger N, Ljungman P, Michallet M, Russell NH, Samson D, Schattenberg A, Sirohi B, Verdonck LF, Volin L, Zander A, Niederwieser D (2005) The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant 35:609\u2013617","journal-title":"Bone Marrow Transplant"},{"key":"12_CR14_12","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3324\/haematol.11353","volume":"92","author":"G Gahrton","year":"2007","unstructured":"Gahrton G, Iacobelli S, Bandini G, Bjorkstrand B, Corradini P, Crawley C, Hegenbart U, Morgan G, Kroger N, Schattenberg A, Schonland SO, Verdonck LF, Volin L, de Witte T, Niederwieser D (2007) Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica 92:1513\u20131518","journal-title":"Haematologica"},{"key":"12_CR15_12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood.V114.22.52.52","volume":"114","author":"G Gahrton","year":"2009","unstructured":"Gahrton G, Bj\u00f6rkstrand B, Iacobelli S, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Musto P, Beksac M, Bosi A, Milone G, Corradini P, Goldschmidt H, de Witte T, Morris C, Niederwieser D (2009) Tandem autologous(ASCT)\/ allogeneic reduced intensity conditioning transplantation (RIC) with identical sibling donor versus ASCT in previously untreated multiple myeloma (MM): Long term follow up of a prospective controlled trial by the EBMT. Blood 114(abstr):52","journal-title":"Blood"},{"key":"12_CR16_12","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1182\/blood-2005-09-3869","volume":"107","author":"F Garban","year":"2006","unstructured":"Garban F, Attal M, Michallet M, Hulin C, Bourhis JH, Yakoub-Agha I, Lamy T, Marit G, Maloisel F, Berthou C, Dib M, Caillot D, Deprijck B, Ketterer N, Harousseau JL, Sotto JJ, Moreau P (2006) Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma. Blood 107:3474\u20133480","journal-title":"Blood"},{"key":"12_CR17_12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbmt.2006.11.011","volume":"13","author":"GE Georges","year":"2007","unstructured":"Georges GE, Maris MB, Maloney DG, Sandmaier BM, Sorror ML, Shizuru JA, Lange T, Agura ED, Bruno B, McSweeney PA, Pulsipher MA, Chauncey TR, Mielcarek M, Storer BE, Storb R (2007) Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma. Biol Blood Marrow Transplant 13:423\u2013432","journal-title":"Biol Blood Marrow Transplant"},{"key":"12_CR18_12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.beha.2006.09.002","volume":"20","author":"L Hambach","year":"2007","unstructured":"Hambach L, Spierings E, Goulmy E (2007) Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract Res Clin Haematol 20:171\u2013187","journal-title":"Best Pract Res Clin Haematol"},{"key":"12_CR19_12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood.V112.11.461.461","volume":"112","author":"H Lokhorst","year":"2008","unstructured":"Lokhorst H, Sonneveld P, van der Holt B, van Oers M, Raymakers R, Zweegman S, Minnema M, Zijlmans M (2008) Donor versus no donor analysis of newly diagnosed myeloma patients included in the HOVON 50\/54 Study. Blood 112(abstr):461","journal-title":"Blood"},{"key":"12_CR20_12","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/blood-2002-09-2955","volume":"102","author":"DG Maloney","year":"2003","unstructured":"Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T, Bruno B, Appelbaum FR, Blume KG, Forman SJ, McSweeney P, Storb R (2003) Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood 102:3447\u20133454","journal-title":"Blood"},{"key":"12_CR21_12","first-page":"861","volume":"90","author":"D Mattei","year":"2005","unstructured":"Mattei D, Mordini N, Vigna Taglianti R, Bruno B, Rapezzi D, Gallamini A (2005) Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse. Haematologica 90:861\u2013862","journal-title":"Haematologica"},{"key":"12_CR22_12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/leu.2008.247","volume":"23","author":"MC Minnema","year":"2008","unstructured":"Minnema MC, van der Veer MS, Aarts T, Emmelot M, Mutis T, Lokhorst HM (2008) Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4(+)Foxp3(+) T cells. Leukemia. 2009; 23:605\u2013607","journal-title":"Leukemia"},{"key":"12_CR23_12","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1182\/blood-2008-07-168823","volume":"112","author":"P Moreau","year":"2008","unstructured":"Moreau P, Garban F, Attal M, Michallet M, Marit G, Hulin C, Benboubker L, Doyen C, Mohty M, Yakoub-Agha I, Leyvraz S, Casassus P, Avet-Loiseau H, Garderet L, Mathiot C, Harousseau JL (2008) Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma. Blood 112:3914\u20133915","journal-title":"Blood"},{"key":"12_CR24_12","doi-asserted-by":"crossref","unstructured":"Remberger M, Mattsson J, Svahn B, Ringd\u00e9n O (2008) Using reduced intensity conditioning and HLA-identcal sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose Bone Marrow Transplant. 2008; 42:769\u2013771","DOI":"10.1038\/bmt.2008.246"},{"issue":"9","key":"12_CR25_12","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1182\/blood-2008-02-141598","volume":"112","author":"L Rosinol","year":"2008","unstructured":"Rosinol L, Perez-Simon JA, Sureda A, de la Rubia J, de Arriba F, Lahuerta JJ, Gonzalez JD, Diaz-Mediavilla J, Hernandez B, Garcia-Frade J, Carrera D, Leon A, Hernandez M, Fernandez Abellan P, Bergua JM, San Miguel J, Blade J (2008) A prospective pethema study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma. Blood 112(9):3591\u20133593","journal-title":"Blood"},{"key":"12_CR26_12","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097\u20132100","journal-title":"Science"},{"key":"12_CR27_12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.trim.2005.03.008","volume":"14","author":"L Ruggeri","year":"2005","unstructured":"Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A (2005) The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. Transpl Immunol 14:203\u2013206","journal-title":"Transpl Immunol"},{"key":"12_CR28_12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2141.2008.07340.x","volume":"143","author":"J Shi","year":"2008","unstructured":"Shi J, Tricot G, Szmania S, Rosen N, Garg TK, Malaviarachchi PA, Moreno A, Dupont B, Hsu KC, Baxter-Lowe LA, Cottler-Fox M, Shaughnessy JD Jr, Barlogie B, van Rhee F (2008) Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol 143:641\u2013653","journal-title":"Br J Haematol"},{"key":"12_CR29_12","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1073\/pnas.0401563101","volume":"101","author":"K Sun","year":"2004","unstructured":"Sun K, Welniak LA, Panoskaltsis-Mortari A, O\u2019Shaughnessy MJ, Liu H, Barao I, Riordan W, Sitcheran R, Wysocki C, Serody JS, Blazar BR, Sayers TJ, Murphy WJ (2004) Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. Proc Natl Acad Sci USA 101:8120\u20138125","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR30_12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.bmt.1705393","volume":"37","author":"NW van de Donk","year":"2006","unstructured":"van de Donk NW, Kroger N, Hegenbart U, Corradini P, San Miguel JF, Goldschmidt H, Perez-Simon JA, Zijlmans M, Raymakers RA, Montefusco V, Ayuk FA, van Oers MH, Nagler A, Verdonck LF, Lokhorst HM (2006) Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplant 37:1135\u20131141","journal-title":"Bone Marrow Transplant"}],"container-title":["Recent Results in Cancer Research","Multiple Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-85772-3_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T04:19:48Z","timestamp":1676089188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-540-85772-3_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783540857716","9783540857723"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-85772-3_12","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"19 March 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}